Global Fecal Microbiota Transplantation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Fecal Microbiota Transplantation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Fecal microbiota transplantation refers to the practice of transplanting stool from a healthy donor into the gastrointestinal tract of the patient. This procedure restores the balance of bacteria in the digestive tract by replenishing the population of ‘good’ bacteria that is either suppressed by the overpopulation of ‘bad’ bacteria or has been killed. Prepared fecal microbiota transplantation is a thoroughly screened process. It is carried out in the lower gastrointestinal tract through colonoscopy or enema and in the upper gastrointestinal tract through the nasoduodenal or nasogastric tube. Currently, fecal microbiota transplantation is being studied for the treatment of Clostridium difficile infection but can be used for the treatment of gut dysbiosis after heavy treatment such as chemotherapy. Patietns with recurrent clostridium infections treated with fecal microbiota transplantation have shown high rates of success. A study has found that 90% recurrent C. difficile cases treated with fecal microbiota transplantation achieve clinical resolution. Thus, this has elevated fecal microbiota transplantation as an emerging treatment for a wide range of disorders, including fibromyalgia, Parkinson’s disease, myoclonus dystopia, chronic fatigue syndrome, multiple sclerosis, insulin resistance, obesity, metabolic syndrome, and autism.
Fecal Microbiota Transplantation report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fecal Microbiota Transplantation market is projected to reach US$ 386.6 million in 2029, increasing from US$ 268 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2029. Demand from Clostridium Difficile Infections and Parkinson Disease are the major drivers for the industry.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fecal Microbiota Transplantation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Rebiotix
Finch Therapeutics
Seres Therapeutics
Crestovo
Segment by Type
Phase-I
Phase-2
Phase-3
Phase-4
Clostridium Difficile Infections
Parkinson Disease
Obesity
Diabetes Mellitus
Autism
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fecal Microbiota Transplantation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Fecal Microbiota Transplantation introduction, etc. Fecal Microbiota Transplantation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Fecal Microbiota Transplantation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Fecal Microbiota Transplantation report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fecal Microbiota Transplantation market is projected to reach US$ 386.6 million in 2029, increasing from US$ 268 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2029. Demand from Clostridium Difficile Infections and Parkinson Disease are the major drivers for the industry.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fecal Microbiota Transplantation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Rebiotix
Finch Therapeutics
Seres Therapeutics
Crestovo
Segment by Type
Phase-I
Phase-2
Phase-3
Phase-4
Segment by Application
Clostridium Difficile Infections
Parkinson Disease
Obesity
Diabetes Mellitus
Autism
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fecal Microbiota Transplantation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Fecal Microbiota Transplantation introduction, etc. Fecal Microbiota Transplantation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Fecal Microbiota Transplantation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices